Julian S. Gangolli, President, North America at GW PHARMACEUTICALS PLC (GWPH), sold 671,928 shares at $14.63 ($10.0M) on 2019-05-10, disclosed to the SEC on 2019-05-14.
Open-market sale of $10.0M GWPH by President, North America. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.63 | 117,876 | $1.7M | 17.3% |
| 2 | $14.70 | 81,156 | $1.2M | 12.0% |
| 3 | $14.80 | 65,268 | $966K | 9.7% |
| 4 | $14.88 | 208,260 | $3.1M | 31.1% |
| 5 | $14.96 | 145,164 | $2.2M | 21.8% |
| 6 | $15.03 | 12,048 |
| $181K |
| 1.8% |
| 7 | $15.12 | 31,368 | $474K | 4.8% |
| 8 | $15.19 | 10,788 | $164K | 1.6% |
| Total | $14.84 avg | 671,928 | $10.0M | 100% |
| Filing → |
| AGN | SELL | 2013-12-30 | $5.8M | — | Filing → |
| AGN | SELL | 2012-11-29 | $8.3M | — | Filing → |